Details of the Drug Reposition

General Information of This Drug (ID: DM5S4LX)

Drug Name
Mirvetuximab soravtansine   DM5S4LX
Synonyms ZOHXWSHGANNQGO-QRVRWUFNSA-N; DB12489
Structure
3D MOL is unavailable 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Ovarian cancer DISZJHAP 2C73 Approved [1]
------------------------------------------------------------------------------------
1 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Endometrial cancer DISW0LMR 2C76 Phase 1 [2]
------------------------------------------------------------------------------------

References

1 FDA Approved Drug Products from FDA Official Website. 2022. Application Number: 761310.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)